Press Releases More Year None202320222021202020192018201720162015 Date Title 2/1/23 G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 1/11/23 G1 Therapeutics to Participate in the Virtual 2023 B. Riley Securities 3rd Annual Oncology Conference 1/9/23 G1 Therapeutics Announces Upcoming 2023 Readouts from its Phase 2 and Pivotal Phase 3 Clinical Trials of Trilaciclib 1/4/23 G1 Therapeutics Provides Initial Update on Phase 2 Bladder Cancer Trial; Progression Free Survival (PFS) Data Expected in Mid-2023 1/3/23 G1 Therapeutics to Participate in the 41st Annual J.P. Morgan Conference
